Immune thrombocytopenia (ITP) is a hematological disorder with an isolated decrease in number of circulating platelets. Bee venom therapy (BVT) is a form of alternative medicine. It is still being practiced in the Middle East and other parts of Asia. In BVT, acupuncture points are used to inject diluted bee venom into the body. The pharmacological basis behind BVT is not fully understood. However, it has been used to treat various medical conditions such as arthritis and low back pain. On the other hand there have been a number of reported complications of BVT use such as ITP. We present a case report on ITP after BVT. A 61 year old lady presented with gum bleeding and ecchymosis and found to have isolated thrombocytopenia (platelet count of 9 × 109/L) after receiving four direct bee sting sessions. There was no evidence of any other risk factors of ITP. Bee venom components and toxicity may be associated with thrombocytopenia as a complication. Further research is needed to postulate guidelines and protocol for BVT. In the meantime, monitoring of the practice of BVT should be made, with an emphasis on patient education regarding the safety profile and associated risks compared to the gained benefits.
SARS-CoV-2 vaccination promises to improve outcomes for patients with COVID-19 pneumonia (most notably those with advanced age and at high risk for severe disease). Here, we examine serum 25-Hydroxyvitamin D (25(OH)D) status and outcomes in both old (>70 years) and young vaccinated (n = 80) and unvaccinated (n = 91) subjects, who were hospitalized due to COVID-19 pneumonia in a single center (Connolly Hospital Dublin). Outcomes included ICU admission and mortality. Serum 25(OH)D levels were categorized as D30 (<30 nmol/L), D40 (30–49.99 nmol/L) and D50 (≥50 nmol/L). In multivariate analyses, D30 was independently associated with ICU admission (OR: 6.87 (95% CI: 1.13–41.85) (p = 0.036)) and mortality (OR: 24.81 (95% CI: 1.57–392.1) (p = 0.023)) in unvaccinated patients, even after adjustment for major confounders including age, sex, obesity and pre-existing diabetes mellitus. While mortality was consistently higher in all categories of patients over 70 years of age, the highest observed mortality rate of 50%, seen in patients over 70 years with a low vitamin D state (D30), appeared to be almost completely corrected by either vaccination, or having a higher vitamin D state, i.e., mortality was 14% for vaccinated patients over 70 years with D30 and 16% for unvaccinated patients over 70 years with a 25(OH)D level greater than 30 nmol/L. We observe that high mortality from COVID-19 pneumonia occurs in older patients, especially those who are unvaccinated or have a low vitamin D state. Recent vaccination or having a high vitamin D status are both associated with reduced mortality, although these effects do not fully mitigate the mortality risk associated with advanced age.
20 March 2019 in JCR: Journal of Clinical Rheumatology
Subdural Hematoma From an Acquired Factor VII Deficiency: Is It the Lupus or the Anticoagulant? Mohammad Abdulsalam;Ahmad Abdulsalam;Levent Özçakar; JCR: Journal of Clinical Rheumatology
Pulmonary embolism (PE) is a fatal condition, with a subsequent variety of complications. Although rare, the ensuing presentation of atrial fibrillation (AF) secondary to PE is evident in the literature. However, there has been no report of AF with slow ventricular response requiring a pacemaker as a complication of PE. A 78-year-old obese female presented to the emergency room with new onset dyspnea. Computed tomography pulmonary angiogram revealed bilateral PE. Twenty-four hours later, the patient developed new onset AF with slow ventricular response. Therefore, a single chamber pacemaker was implanted. PE causing AF with slow ventricular response has not been reported or explained in the literature. The mechanism of this complication is yet to be understood and will require further investigation to explain this newly presented relationship.
Introduction: Obstructive sleep apnea (OSA) has been linked to metabolic and musculoskeletal alterations, but its relationship with sarcopenia remains unclear. Aims: To compare sarcopenia prevalence between patients with OSA and controls using ultrasound-based assessment. Method: patients (≥50 years) with confirmed OSA (apnea-hypopnea index ≥5/hour) were included. Quadriceps muscle thickness was measured via ultrasonography, and sonographic thigh adjustment ratio (STAR) was calculated as muscle thickness/BMI. Grip strength and chair stand test (CST) were assessed. Sarcopenia was diagnosed using ISarcoPRM criteria: low STAR (<1.0 females, <1.4 males) with low grip strength (≤19 kg females, ≤32 kg males) and/or CST ≥12 seconds. Results: 208 adults (104 OSA patients and 104 controls) were included. The groups were similar regarding age, sex, body mass index, physical activity, smoking, diabetes mellitus and hypertension (all p-value>0.05). OSA patients had lower anterior thigh MT (31.7±7.7 vs. 37.8±9.1 mm) and STAR values (0.93±0.28 vs. 1.16±0.33), but better CST performance (8.8±3.7 vs. 12.4±5.0 sec)(all p-value0.05). Sex-specific subgroup analysis revealed that although no difference was observed among females (p>0.05), the prevalence of sarcopenia in males with OSA twice as high as in male controls (28.1% vs. 14.0%, p-value=0.066). Conclusion: Despite reduced muscle thickness in OSA patients, the overall sarcopenia prevalence was comparable to controls. The trend toward higher sarcopenia in males suggests sex-specific vulnerability. These findings indicate that OSA may adversely affect muscle quality and structure, warranting further studies with larger sample size.